 As something you need to know, federal officials have given the green light to a second Alzheimer's drug. The FDA announced its approval of Eli Lilly's Kesunla drug Tuesday after finding it's effective in slowing Alzheimer's disease. The decision allows patients a new option to help battle the memory-destroying ailment.